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Summary
Identifying cellular and molecular differences between human and non-human primates (NHPs) is 
essential to the basic understanding of the evolution and diversity of our own species. Until now, 
preserved tissues have been the main source for most comparative studies between humans, 
chimpanzees (Pan troglodytes) and bonobos (Pan paniscus)1,2. However, these tissue samples do 
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not fairly represent the distinctive traits of live cell behavior and are not amenable to genetic 
manipulation. We hypothesized that induced pluripotent stem cells (iPSCs) could be a unique 
biological resource to elucidate relevant phenotypical differences between human and NHPs and 
that those differences could have potential adaptation and speciation value. Here, we describe the 
generation and initial characterization of iPSCs from chimpanzees and bonobos as novel tools to 
explore factors that have contributed to great ape evolution. Comparative gene expression analysis 
of human and NHP iPSCs revealed differences in the regulation of Long Interspersed Nuclear 
Element-1 (LINE-1 or L1) transposons. A force of change in mammalian evolution, L1 elements 
are retrotransposons that have remained active during primate evolution3-5. Decreased levels of L1 
restricting factors APOBEC3B (A3B)6 and PIWIL27 in NHP iPSCs correlated with increased L1 
mobility and endogenous L1 mRNA levels. Moreover, results from manipulation of A3B and 
PIWIL2 levels in iPSCs supported a causal inverse relationship between levels of these proteins 
and L1 retrotransposition. Finally, we found increased copy numbers of species-specific L1 
elements in the genome of chimpanzees compared to humans, supporting the idea that increased 
L1 mobility in NHPs is not limited to iPSCs in culture and may have also occurred in the germline 
or embryonic cells developmentally upstream to germline specification during primate evolution. 
We propose that differences in L1 mobility may have differentially shaped the genomes of 
humans and NHPs and could have ongoing adaptive significance.
Humans, chimpanzees and bonobos are genetically very similar, sharing nearly 98% of their 
alignable genomic sequence1-3. However, cellular and molecular phenotypes, especially at 
identical stages of development, are difficult to establish, mainly due to limited access to 
embryonic material from human and NHPs8. We reprogrammed fibroblasts from two 
bonobos and two chimpanzees into iPSCs as previously described9,10 (Extended Data Fig. 
1a). After culture in human ESC (hESC)-supporting conditions, NHP iPSC colonies could 
be distinguished by the high nucleus-to-cytoplasm ratio morphology. iPSC clones from both 
species continuously expressed pluripotency markers, retained undifferentiated morphology 
in culture, and maintained a normal karyotype (Fig. 1a). After embryoid body (EB)-
mediated differentiation in vitro, clones contained tissue derivatives from the three 
embryonic germ layers and down-regulated expression of pluripotency markers (Fig. 1b). 
iPSCs selected clones were also able to differentiate into the three embryonic germ layers in 
vivo as shown by analysis of teratomas in nude mice (Fig. 1c). Together, these data 
demonstrate that NHP iPSC clones re-established pluripotency at the molecular and cellular 
levels.
To gain insight into differences in gene expression between human and NHP iPSCs, we 
performed RNA-seq analyses on four human, two chimpanzee and two bonobo iPSC lines 
(Extended Data Fig. 1b). The expression profiles of iPSCs from the three species clustered 
together with hESCs (HUES6 and H1) and were distinguishable from hESC-derived neural 
precursor cells (NPCs) (Fig. 2a), chimpanzee and bonobo iPSCs clustered closer to each 
other than to human iPSCs (Fig. 2a). We then performed pairwise comparisons of protein-
coding gene expression levels (Fig. 2b). Venn diagrams represent expressed genes with non-
significant differences between species (purple) and up-regulated genes with estimated false 
discovery rates (FDR) of less than 5% and a fold change greater than 2-fold (pink and blue). 
Comparison between human and NHP (Fig. 2b bottom-right) revealed 1,376 genes with 
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elevated expression in human iPSCs and 1,042 common genes with elevated expression in 
NHP iPSCs, whereas no significant differences were observed in 11,585 protein-coding 
genes. Next, we focused on genes differentially expressed between human and NHP iPSCs 
(Fig. 2c-e, Extended Data Fig. 1c,d), and found, among the top 50 genes with elevated 
expression in human iPSCs compared to NHP iPSCs, two genes involved in restriction of L1 
retrotransposition, namely A3B and PIWIL2 (Fig. 2d).
Active, full-length L1 elements have the ability to move from one location in the genome to 
another by a copy-paste mechanism called retrotransposition11. Active L1 elements have 
been detected in both germline and somatic tissues, and can impact genome integrity12,13. 
As uncontrolled retrotransposition activity can be deleterious to the host14, organisms have 
evolved mechanisms to control L1 mobility11. A3B is a member of the APOBEC3 family of 
cytidine deaminases that can inhibit L1 mobility in different cell types, including human 
embryonic stem cells (hESCs) and iPSCs, via a still unclear mechanism6,15,16. PIWIL2 is an 
effector of the piRNA pathway involved in L1 silencing mainly in germ line7.
To confirm differences in A3B and PIWIL2 in human versus NHP iPSCs, we first cloned 
their cDNAs from the three species, and found a high degree of conservation between 
human and NHPs (Extended Data Fig. 2). Quantification of A3B mRNA levels by qPCR 
confirmed significantly higher levels (~30-fold) of A3B in both human iPSC lines compared 
to NHP iPSCs (Fig. 3a). Levels of PIWIL2 mRNA were 16-fold higher in human iPSC lines 
than in NHP iPSCs (Fig. 3b). PIWIL2-mediated control of transposons is most active in 
germline and we observed that levels of PIWIL2 mRNA are 20 to 40-fold lower in human 
iPSCs than in testis (Extended Data Fig. 3a). The increased expression observed in human 
iPSCs appears to be specifically restricted to A3B and PIWIL2 compared to other members 
of these protein families (Extended Data Fig. 3b-c). Differences in A3B and PIWIL2 
mRNA levels reflected higher A3B and PIWIL2 protein levels in human versus NHP iPSCs 
(Fig. 3c).
Ectopic expression of A3B has been shown to inhibit the mobility of human L1 reporter 
elements6,17 (Extended Data Fig. 4a)18,19. In 293T cells, ectopic expression of human A3B 
significantly reduced L1-expressing firefly luciferase (L1-Luc)18,19 mobility by 5-fold 
compared to control plasmid or a plasmid expressing A3G, another APOBEC3 protein that 
lacks anti-L1 activity (Fig. 3d)17. We also found a significant decrease in L1-Luc 
retrotransposition in cells overexpressing PIWIL2 compared to control transfected cells 
(Fig. 3d). We then confirmed that human L1 can retrotranspose in hESCs and hiPSCs under 
our culture conditions, as previously shown15,20,21 (Fig. 3e). Since we found reduced levels 
of L1 restriction factors A3B and PIWIL2 in NHPs, we compared L1 activity in human 
versus NHP iPSCs using the human L1-EGFP reporter element18,19. L1 retrotransposition 
was significantly higher in NHP compared to human iPSC lines, with 10- and 8-fold 
increases in EGFP-positive cells in chimpanzee and bonobo iPSCs, respectively (Fig. 3f-g). 
To test whether the differential L1 regulation in iPSCs is specific to human L1, we measured 
the activity of a NHP L1 element in iPSCs. We generated a retrotransposition-competent 
chimpanzee L1-EGFP reporter element (Chimp-L1) (Extended Data Fig. 5), and observed 
that Chimp-L1 was significantly more active in NHP iPSCs than in human iPSCs (Fig. 3h), 
suggesting that the decreased L1 activity in human iPSCs is not specific to human L1 
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element, and that human iPSCs are more efficient in repressing L1 retrotranspostion than 
NHP iPSCs.
To analyze the contribution of endogenous A3B to the differential L1 activity observed 
among primate cells, we generated human ESCs and iPSCs with decreased levels of A3B 
(Fig. 4a and Extended Data Fig. 4b,c). Stable knockdown of A3B (shA3B) resulted in a 
significant increase in L1-EGFP activity compared to shScramble (shScr) control cells in 
human iPSCs (Fig. 4a-b). Knockdown was specific to A3B, not affecting other APOBEC3s 
(Extended Data Fig. 4d-f). As expected, L1 mobility was significantly decreased in both 
chimpanzee and bonobo iPSC lines after A3B overexpression (Fig. 4c). Similarly, 
overexpression of chimpanzee or bonobo PIWIL2 in NHP iPSCs reduced L1 mobility to 
levels detected in human iPSCs (Fig. 4d). We did not observe differences in the levels of 
L1-EGFP mRNA expressed from transfected L1 plasmid or in L1 promoter activity between 
human and NHP iPSCs (Extended Data Fig. 4g-i). Together these results suggest that 
differences in A3B and PIWIL2 expression levels contribute to higher L1 retrotransposition 
in NHP iPSCs compared to human iPSCs
PIWIL2 repression of transposons is mediated through piRNAs22. Thus, we analyzed the 
presence of PIWIL2-bound piRNAs in doxycycline-inducible human iPSCs expressing 
Flag-tagged PIWIL2 by immunoprecipitation and subsequent 5’ end labeling. Analysis of 
PIWIL2-associated small RNAs revealed the presence of ~26-30 nt RNAs only in cells 
expressing Flag-PIWL2 but not in control cells or in pull-downs with control antibody (Fig. 
4e and Extended Data Fig. 6a,b). Next, to probe for the presence of L1-targeting-piRNAs 
we characterized the small RNA populations in human iPSCs by small RNA-seq analysis 
(Extended Data Fig. 6c,d, Supplementary Table 1 and 2). We detected 272 and 229 
annotated piRNAs in human iPSC1 and iPSC2, respectively (Extended Data Fig. 6d-f and 
Supplementary Table 2). In addition, we observed a number of 26-33 nt small RNAs 
mapping to the consensus human-specific L1 element (L1Hs) sequence (Fig. 4f, Extended 
Data Fig. 7a,b), including 12 and 10 out of the 37 annotated piRNAs mapping to L1Hs in 
piRNAbank (http://pirnabank.ibab.ac.in/) in hiPSC1 and hiPSC2, respectively (Extended 
Data Fig. 6e,g and 7a-c). Together these results demonstrate the presence of piRNAs 
complementary to L1Hs in human iPSCs.
We then asked whether different levels of L1 reporter mobility between human and NHP 
iPSCs reflect differences in endogenous L1 activity. First, we analyzed endogenous L1 RNA 
levels by qPCR and found higher levels of endogenous L1 mRNA in chimpanzee and 
bonobo compared to human iPSCs (Fig. 4g and Extended Data Fig. 8a-c). Next, we 
examined the number of L1 elements in human and chimpanzee genomes to assess 
differences in recent L1 mobility. We did not observe major differences in the number of L1 
elements for older families (L1PA4, L1AP3 and L1PA2; approximately 18, 12.5 and 7.6 
Million year old, respectively)23,24 (Fig. 4h). However, we did observe significantly higher 
numbers of chimpanzee-specific L1 elements (L1Pt) compared to L1-Hs elements 
(L1Hs)25,26(Fig. 4h). Differences in expression of A3B and PIWIL2 suggest that L1 
mobility may have been altered at a relatively recent evolutionary divergence. Therefore, 
using divergence as a measurement of L1 age, we estimated the number of species-specific 
L1 loci and found that the number of chimpanzee-specific loci was significantly higher than 
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the number of human-specific loci (Fig. 4i and Extended Data Fig. 8d-g). The increased 
number of species-specific L1 loci in chimpanzee suggests that endogenous L1 has been 
more active in NHP genomes, correlating with the decreased levels of A3B and PIWIL2.
Here we report that iPSCs from both chimpanzees and bonobos have increased L1 mobility. 
Different rates of L1 activity could lead to significant changes in genomic structure and 
function, and could potentially impact adaptation. The human population has gone through 
one or more bottlenecks throughout evolution that might have contributed to decreased 
genetic diversity27. Chimpanzees and bonobos, in contrast, have increased levels of genetic 
diversity when compared to humans28. This idea is also supported by data showing that 
there is substantially more genetic difference among individuals within chimpanzee troops 
in West Africa than among all living humans29. While it remains unclear what the main 
generators of the phenotypic differences between us and our closest living relatives are 
(despite the extreme genetic similarity), we propose that L1 mobility could be playing a role 
in differentially shaping the genomes of humans and NHPs, providing an extra layer of 
variability to the latter. In fact, recent studies have suggested that ongoing L1 
retrotransposition may contribute to inter individual genetic variation30. In this work we also 
present a new perspective on the use of iPSC technology as a powerful tool for the study of 
early stages of development and possible validation of evolutionary genomic and 
transcriptomic modifications that identify humans as outliers among primates. The great 
apes iPSCs that we describe here can also be used for comparative studies of any derivative 
pluripotent or terminally differentiated cell types, limited solely by the availability of 
differentiation protocols.
METHODS
Cell culture and retrovirus infection
hESC Hues6 and H1, human iPSC lines WT-33, ADRC-40 (human IPSC1 and IPSC2 in this 
work, respectively) and WT-126 were previously described31. Fibroblasts from human 
GM22159 (WT-9), Pan troglodytes (Chimpanzees: PR00818 and PR01209) and from Pan 
paniscus (Bonobos: AG05253 and PR01086) were acquired from Coriell Cell Repositories 
(NJ) (Extended Data Table 1). All fibroblasts were cultured in Minimum Essential 
Medium (Invitrogen) supplemented with 10% fetal bovine serum (HyClone Laboratories). 
Retroviral vectors expressing Oct4, c-Myc, Klf4 and Sox2 human cDNAs from Yamanaka's 
group9 were obtained from Addgene. Recombinant viruses were produced by transient 
transfection in 293T cells, as previously described32. Two days after infection, cells were 
plated on mitotically inactivated mouse embryonic fibroblasts (Chemicon) with hESC 
medium. After 2 to 4 weeks, iPSCs colonies were picked manually and directly transferred 
to feeder-free conditions on matrigel-coated dishes (BD) using mTeSR™1 (StemCell 
Technologies). Established iPSCs colonies were kept in feeder-free conditions indefinitely 
and passed using mechanical dissociation. Embryoid body (EB)-mediated differentiation in 
suspension was carried out for 10 days in the absence of growth factors. The use of 
chimpanzee and bonobo fibroblast samples was approved by the US Fish and Wildlife 
Service, under the permit MA206206. Protocols describing the use of iPSCs and hESCs 
were previously approved by the University of California San Diego and Salk Institute 
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Institutional Review Board and the Embryonic Stem Cell Research Oversight Committee31. 
To generate stable shA3B cells lines, Hues6, WT33 and ADRC-40 cells were transduced 
with lentiviruses expressing shRNAs and selected for puromycin resistance. pLKO.1-based 
lentiviral plasmids encoding shRNAs against A3B (RHS3979-99216651 and 
RHS3979-99216658) were obtained from Open Biosystems. Recombinant lentiviruses were 
produced by transient transfection on 293T cells as previously described 33.
Teratoma formation in nude mice
Around 1-3 ×106 cells were injected subcutaneously into the dorsal flanks of nude mice 
(CByJ.Cg-Foxn1nu/J) anesthetized with isoflurane. Five to 6 weeks after injection, 
teratomas were dissected, fixed overnight in 10% buffered formalin phosphate and 
embedded in paraffin. Tissues were then prepared for histopathologic analysis by the UCSD 
Mouse Phenotyping Services (UCSD, CA http://mousepheno.ucsd.edu). Briefly, the tissue 
was sectioned and stained with hematoxylin and eosin. Control mice injected with 
fibroblasts failed to form teratomas.
Karyotyping
Standard G-banding chromosome analysis was performed by Cell Line Genetics (CLG, 
Madison, WI). Diploid human cells with 2n=46 chromosomes; bonobo and chimpanzee with 
2n=48 chromosomes.
RNA extraction and RT-PCR
Total cellular RNA was extracted from ~5×106 cells using the RNeasy Protect Mini kit or 
RNeasy Plus kit (Qiagen, Valencia, CA), according to the manufacturer's instructions, and 
was reverse transcribed using the SuperScript III First-Strand Synthesis System RTPCR 
from Invitrogen. For iPSC markers, cDNA was amplified by PCR using Accuprime Taq 
DNA polymerase system (Invitrogen). Primer sequences are shown in Extended Data 
Table 1. PCR products were separated by electrophoresis on a 2% agarose gel, stained with 
ethidium bromide and visualized by UV illumination. Total RNA samples from human testis 
were obtained from Clontech. Small RNA was extracted using the mirVana kit (Ambion).
Quantitative RT-PCR
RNA was extracted using a QIAGEN RNeasy Plus kit or TRIzol (Life Technologies) and 
then retrotranscribed to cDNA with the Superscript III First-Strand synthesis system 
(Invitrogen). qRT-PCRs were carried out using SYBR Green mix (Roche) or TaqMan 
Assays (Life Technologies) using ABI Prism 7900HT sequence detection system (Applied 
Biosystems). The primers and Taqman sets used in this work are described in Extended 
Data Table 1. Data analysis was performed with SDS 2.3 software (Applied Biosystems). 
Primer efficiency was verified by linear regression to the standard curve. Values were 
normalized to GAPDH, HPRT or b-Actin. Reactions were carried out in triplicate and data 
were analyzed using the comparative (delta-delta Ct) method. For A3B and PIWIL2, RNA 
levels were normalized to GAPDH or b-Actin and represented as relative to IPSC-1. 
Relative A3B and PIWIL2 mRNA levels normalized to GAPDH for each individual iPSC 
line and fibroblasts are shown in Extended Data Fig. 9. The reduced levels of A3B in NHP 
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iPSC were not due to an A3B deletion polymorphism previously described in human 
individuals34 (data not shown). For L1 RNA quantitative RT-PCR, values representing the 
average of relative levels for L1 RNA (5’UTR, ORF1 and ORF2) were calculated, and were 
normalized to Actin mRNA levels. L1 levels are shown as relative to IPSC-1. Quantitative 
RT-PCR analysis of EGFP expression in iPSC lines transfected with L1-EGFP plasmid was 
carried out 60-72 hours post-transfection. At this time after transfection, EGFP RNA 
expressed from retrotransposed L1-EGFP will be insignificant compared to L1-EGFP 
plasmid-driven expression. EGFP levels were normalized to GAPDH or puromycin. L1-
EGFP contains a puromycin expression cassette under PGK promoter control. Thus, 
puromycin expression can be used as normalizer for transfection. IPSCs from two different 
individuals per species were transfected, and EGFP levels are shown as relative to human 
iPSCs.
Plasmids
Human APOBEC3B cDNA from WT-33 and ADRC-40 iPSCs was amplified using Phusion 
high-fiidelity polymerase (New England BioLabs) and primers described in Extended Data 
Table 1. A3B cDNA fused to HA-tag was then inserted into KpnI/XbaI digested 
pcDNA3.1+ (pcDNA3-A3B) as previously described 35. Similarly, PIWIL2 cDNAs were 
amplified from human and NHP iPSCs as described above and inserted into pEF-BOS-EX 
using EcoRI/SalI36. The plasmid expressing APOBEC3G was previously described 35.
RNA library generation and deep sequencing
PolyA+ RNA was fragmented and prepared into sequencing libraries using the Illumina 
TruSeq RNA sample preparation kit and analyzed on an Illumina HiSeq 2000 sequencer at 
the UCSD Biomedical Genomics Laboratory (BIOGEM). cDNA libraries were prepared 
from four human, two chimpanzee and two bonobo iPSC lines derived from fibroblasts (two 
clones each, except for human WT9 and WT126), and two hESCs (Hues6 and H1). Libraries 
were sequenced using paired-end 2× 100 bp reads at a depth of 15-30 million reads per 
library (250 ± 25 bp fragments) (Extended Data Fig. 1b). Paired end reads from all libraries 
were mapped to both the human (hg19, GRCh37) and chimpanzee (panTro3, CGSC 2.1.3) 
genomes using STAR (v2.2.0c)37. To compare gene expression between human and NHP 
iPSCs, we first mapped paired end reads from all libraries to both human and chimpanzee 
genomes and then calculated gene expression read counts relative to human RefSeq 
transcripts. Due to the lack of annotation in the chimpanzee genome, human gene models 
(RefSeq) were used to quantify gene expression. To avoid bias introduced by genome 
insertions and deletions, only reads mapping to both the human and chimpanzee genomes 
uniquely were used from each sample when comparing gene expression values (~4% of 
reads mapped to only one genome per sample). To calculate gene expression, read counts in 
the exons of RefSeq transcripts where calculated using HOMER38. Gene expression 
clustering was carried out using Gene Cluster 3.0 and visualized with Java Tree View39,40. 
EdgeR was used to identify differentially expressed genes comparing human samples with 
NHPs, and pairwise between bonobo, chimpanzee, and human41. Functional enrichment 
analysis was restricted to differentially expressed coding genes with false discovery rates 
less than 5% and a fold change greater than 2-fold. We further restricted genes to contain an 
average of 10 normalized reads across sample groups to remove genes with very low 
Marchetto et al. Page 7
Nature. Author manuscript; available in PMC 2014 June 20.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
expression. Gene Ontology functional enrichment for biological processes (level 2) was 
carried out using DAVID42, Homo sapiens whole genome was set as background.
Small RNA library generation and deep sequencing
Small RNA (15-40 nt) libraries were prepared using the Illumina TruSeq Small RNA sample 
preparation kit and analyzed on an Illumina HiSeq 2000 sequencer at the Beijing Genomics 
Institute. Libraries were sequenced using single-end reads at a depth of 15-25 million reads 
per library. Adapter sequences were clipped from the 3’ end of each read and then aligned to 
the human (hg19, GRCh37) genome or to the L1Hs consensus sequence (Repbase43) using 
Bowtie2 (v4.1.2)44. Reads aligning to miRBase-defined miRNA transcripts were quantified 
using HOMER. Matches to previously identified human piRNAs were restricted to small 
RNAs with lengths between 26 and 33 nt with 5’ ends within 2 nt of previously identified 
piRNA 5’ ends based on piRNABank (http://pirnabank.ibab.ac.in/)45.
L1 retrotransposition
Reporter L1 elements are tagged with a reporter gene (EGFP or firefly Luciferase (Luc)) 
such that only cells that complete a round of retrotransposition will express the reporter 
gene46. Three L1 reporter plasmids were used in this work. L1-EGFP18,46 was previously 
described and was a gift from Dr. J.V. Moran. L1 luciferase-tagged plasmids (pYX014 and 
pYX017)19 were obtained from W. An. In pYX014, L1 is regulated by its native promoter 
(5’-UTR) and, in pYX017, by the heterologous promoter CAG. pYX014 and pYX017 
plasmids contain a renilla luciferase expression cassette that allows for control of 
transfection efficiency. L1 assays in 293T cells were carried out as previously described 47. 
293T cells were transfected with L1 reporter plasmid together with control plasmid or 
plasmids expressing A3B, A3G or PIWIL2 using polyethylenimine (PEI). L1-Luciferase 
retrotransposition was measured by quantification of luciferase activity using the Dual-Glo 
luciferase reporter assay (Promega) and normalized to renilla luciferase. L1-Luc inhibition 
in the presence of A3B or PIWIL2 was independent of the promoter driving L1 expression 
(data not shown). Inhibition levels of L1 retrotransposition by A3B and PIWIL2 were 
comparable between the three L1 reporter plasmids used in this study. Plasmid transfections 
of iPSCs were performed by electroporation of L1-EGFP plasmid following the 
manufacturer's instructions (Lonza/Amaxa Nucleofactor, Kit V). The cells were then 
cultured under normal conditions for 10 days and the percentage of retrotransposition was 
measured by fluorescent activated cell sorting (FACS) of EGFP-positive cells. 
Electroporation efficiency of the L1-EGFP plasmid in human and NHP iPSC was controlled 
by transfecting a cassette expressing EGFP and analyzed by FACS after 48h. Human and 
NHP iPSC lines had similar transfection efficiency rates. To test the effect of A3B and 
PIWIL2 overexpression on L1 activity in NHP iPSCs, human A3B and human, chimpanzee 
or bonobo PIWIL2 cDNAs were electroporated. All experiments were performed at least 
three times independently. L1 mobility assays are shown as relative value compared to mock 
transfections or human IPSC-1 and represented as mean±SEM of at least three independent 
experiments.
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Identification and cloning of a retrotransposition-competent Chimpanzee L1
To clone an intact L1 and generate a chimpanzee L1-EGFP reporter plasmid, we followed a 
modification of the strategy previously described48. Intact L1Pt elements were identified in 
the Chimpanzee genome (CSAC 2.1.4/panTro4, UCSC) through Blat and L1Xplorer 
analyses49. Among the identified intact full-length L1Pt elements, we amplified the L1 
element located in chromosome 7: 11771100-11777132 of the chimpanzee genome from 0.2 
ng of genomic DNA extracted from chimpanzee iPSC1. Primers were designed to match 
unique sequences flanking 5’ and 3’ of the L1Pt and PCR reactions were performed using 
Phusion High-Fidelity polymerase (NEB). PCR product was sequenced to confirm 
intactness (Extended Data Fig. 5). A second PCR was performed using the first PCR 
product as template to introduce a NotI site upstream the 5’end of L1Pt. The second PCR 
product was digested with NotI/BstZ17I (New England Biolabs) and inserted into NotI/
BstZ17I-digested pL1-EGFP replacing the human-L1 element to generate L1IN71 by using 
Rapid Ligation kit (Roche). L1IN71 contains a full-length L1Pt element tagged with the 
EGFP retrotransposition reporter cassette. Primers used for cloning L1IN71 are show in 
Extended Data Table 1.
L1 promoter activity
Human and chimp L1 promoters (L1 5’UTR) were amplified by PCR from L1-EGFP and 
L1IN71 plasmids, and inserted into XhoI/HindIII digested pGL4.10 (Promega) upstream 
firefly luciferase cDNA (L15’UTR plasmids). To quantify L1 promoter activity, L15’UTR 
plasmids were co-transfected into human and NHP iPSC lines with a plasmid expressing 
Renila luciferase. 72 hours post-transfection luciferase activity was quantified and firefly 
luciferase signal were normalized to renilla luciferase signal. Results are shown as relative 
to human L1 5’UTR activity in human iPSCs. Two iPSC lines from different individuals 
(iPSC1 and iPSC2) per species were transfected. Primers used for cloning L1 5’UTRs are 
show in Extended Data Table 1.
Quantification of reference genome-encoded L1 insertions
Quantification of L1-derived genomic sequences was based on Repbase defined elements 
annotated by RepeatMasker (http://www.repeatmasker.org). L1 genomic positions for 
human (hg19, GRCh37) and chimpanzee (panTro3, CGSC 2.1.3) genomes were 
downloaded from the UCSC Genome Browser annotation database50. Due to the large 
number of unfinished gaps in the chimpanzee genome assembly greater than 2 kb in size, 
only truncated L1 elements between 100 bp and 1 kb in length were considered in this 
analysis. Most of these represented the 3’ end of L1 elements. L1 elements were separated 
based on their annotation as L1HS, L1Pt, L1PA2, L1PA3, or L1PA4 and were plotted as a 
histogram relative to their divergence values, which indicates the fractions of nucleotides 
that are mutated relative to the consensus element for each family. To estimate the 
variability of L1 coverage across the genome, each genome was fragmented into 1 Mb 
sections and then was randomly sampled in ten separate groups to calculate the standard 
deviation in number of L1 elements across different regions of the genome. A strong 
concentration of L1 elements in a few specific regions of the genome would result in a very 
high variance between groups, whereas uniform insertion across the genome would result in 
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a low variance. This standard deviation between each sampling was reported as a function of 
divergence for each class of L1 elements.
To identify reference L1 elements that were inserted into the genome after the last common 
ancestor for human and chimpanzee, L1 elements were mapped between homologous 
regions of each genome using the UCSC LiftOver tool. If an element failed to map between 
genomes, the 100 bp regions immediately upstream and downstream of the L1 element were 
also mapped between genomes using the LiftOver tool. If the upstream and downstream 
regions both mapped to the other genome, then the L1 element was mostly likely a result of 
a recent retroviral insertion. If only one or neither of the upstream and downstream regions 
mapped between genomes, the region was more likely the result of a genomic duplication or 
deletion and was discarded from the analysis. Error bars (standard deviation) represent the 
differences in L1 density based on the sampling of different genomic regions and represents 
the variability of L1 coverage across the genomes.
Immunocytochemistry
Cells were fixed in 4% paraformaldehyde and then permeabilized with 0.5% Triton-X100 in 
PBS. Cells were then blocked in 5% donkey serum for 1 hour before incubation with 
primary antibody overnight at 4°C. After three washes with PBS, cells were incubated with 
secondary antibodies conjugated to fluorophors (Jackson Immuno Research) for 1 hour at 
room temperature. Fluorescence was detected using a Zeiss inverted microscope.
Immunoblotting
Immunoblotting was performed as previously described (Narvaiza et al. 2009). Cell pellets 
were lysed in lysis buffer supplemented with Complete protease inhibitor cocktail (Roche) 
for 30 min on ice35. Protein concentrations from whole cell lysates were quantified by BCA 
assay (Bio-Rad). Proteins were separated in 4–12% Acrylamide Bis-Tris NuPage gels in 
MOPS buffer (Invitrogen) and transferred onto Hybond nitrocellulose membranes 
(Amersham Biosciences).
Antibodies
Primary antibodies used in this study were: TRA-1-81 (1:100, Millipore, MAB4381), Nanog 
(1:500, R&D Systems, AF1997), APOBEC3B (D-15) (1:500, Santa Cruz, sc-86289), 
PIWIL2 (1:1000, R&D Systems, AF6558), GFP (1:200, Molecular Probes-Invitrogen, 
A-6455), Flag (1:1000 Sigma, F7425) and HA (1:1000 Sigma, H6908). All secondary 
antibodies were purchased from Jackson ImmunoResearch.
PIWIL2 RNPs immunoprecipitation and end labeling
Tetracycline-inducible human iPSCs expressing flag-tagged PIWIL2 were generated by 
transduction with lentiviruses (Lv)51. Cells were first transduced with a Lv expressing 
tetracycline transactivator rtTA (LvXEtO). After 10 days of culture in growth media with 
Neomycin (Neo), Neo-resistant colonies were then transduced with a Lentivirus expressing 
Flag-PIWIL2 under the control of a tetracycilne-inducble promoter (LvXTPFlagPIWIL2) 
and selected for resistance to puromycin. For PIWIL2 RNP immunoprecipitation, ~3×107 
human iPSCs were treated with doxycycline for 72 hrs, and pelleted cells were resuspended 
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in 1 ml of Lysis Buffer 1 (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM MgCl2, 0.5% 
NP40, 1% glycerol, 1 mM DTT, 0.1 U/μl RNAse inhibitor (Ambion), Complete EDTA-free 
protease inhibitor (Roche)). Cell lysates were cleared by centrifugation at 20,000 g for 20 
min at 4°C. Cleared lysates were incubated with EZview Red FLAG M2 Affinity Gel 
(Sigma) for 3 hrs at 4°C and washed 5 times with wash buffer (Lysis Buffer 1 without 
glycerol). Co-immunoprecipitated RNAs were extracted with Trizol, followed by 
precipitation with isopropanol and glycogen (Ambion). Isolated RNA was 5’ labeled with 
[γ-32P]-ATP using T4 polynucleotide kinase (NEB), resolved on 15% PAGE TBE urea gels 
along with radiolabeled Decade size marker (Ambion) and visualized in a Typhoon 
phosphorimager (Amersham Biosciences). Control immunoprecipitations were carried out 
with lysates from cells without doxycycline induction, from doxycycline-induced GFP 
expressing hiPS cells or with control antibody (anti-HA).
Data deposition
RNA-Seq and small RNA-seq data have been deposited in the Gene Expression Omnibus 
under accession number GSE47626. GenBank accession numbers: KF651164 (P. paniscus 
PIWIL2), KF651165: (H. sapiens PIWIL2), KF651166 (P. troglodytes PIWIL2), KF651167 
(H. sapiens APOBEC3B), KF651168 (P. troglodytes APOBEC3B), KF651169 (P. paniscus 
APOBEC3B) and KF661301 (L1Pt in Chimp-L1 plasmid).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Characterization of iPSCs derived from the three primate species
(a) Morphology of fibroblasts and iPSCs. No karyotypic abnormalities were observed in 
iPSCs clones. Immunofluorescence for pluripotency makers, Tra-1-81 and Nanog in iPSCs. 
Bar = 10 μm. (b). RT-PCR for undifferentiation marker (Nanog) and for the three germ cell 
layers (Musashi, Brachyury and AFP) in human, chimpanzee and bonobo iPSCs (H, C and 
B, respectively) and in differentiated embryoid bodies (EBs). (c) Hematoxylin and eosin 
staining of teratoma sections showing differentiation into three germ layers: goblet cells in 
gastro-intestinal tract (endo); neuro retinal epithelium (ecto) and muscle and cartilage/bone 
(meso). Bar = 150 μm.
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Figure 2. RNA-seq profiling of human and NHP iPSCs
(a) High-throughput sequencing of 14 RNA samples corresponding to four human, two 
chimp and two bonobo iPSC lines. hESCs (H1 and Hues6, arrowheads) and hESC-derived 
neural progenitor cells (NPCs). Heat map representation of mapped reads corresponding to 
protein-coding genes. (b) Venn diagrams showing pairwise comparison of protein-coding 
genes. Pink and blue: significantly up-regulated genes (FDR<0.05 and fold change>2) 
Purple: expressed genes with no significant differences in mRNA levels between compared 
species. (c) Heat map representation of differentially expressed protein-coding genes with 
FDR<0.05 and FC>2 between human and NHP iPSCs. (d, e) List of the top 50 differentially 
expressed genes in human iPSCs compared to NHP iPSCs with elevated expression in 
human iPSCs (d) and elevated expression in NHPs (e). PIWIL2 and APOBEC3 were 
expressed at significantly higher levels in human iPSCs than in NHP iPSCs (positions 8 and 
38 in table d, respectively). Rank, gene name, Logarithmic base 2 fold change (Log FC), and 
false discovery rates (FDR) are shown.
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Figure 3. Reduced levels of A3B and PIWIL2 and increased L1 mobility in NHP iPSCs
(a,b) Quantitative PCR analysis of A3B (a) and PIWIL2 (b) expression in human and NHP 
iPSCs (Extended Data Fig. 2 and 9). (c) Immunoblot for A3B and PIWIL2. (d) Effect of 
A3B and PIWIL2 on L1-luciferase retrotransposition in 293T cells. 293T cells were co-
transfected with L1-Luc plasmid (pYX017)19 plus control, PIWIL2, A3B or A3G 
expressing plasmid. L1-Luc mobility was calculated as firefly luciferase units relative to 
renilla luciferase units. L1 activity is shown as relative to control plasmid. (e) Comparable 
levels of L1-EGFP18 mobility in hESCs and hiPSCs. L1-GFP mobility is shown as 
percentage of EGFP-positive cells by FACS relative to hESCs. (f) L1-EGFP 
retrotransposition in human, chimp and bonobo iPSCs. L1 mobility was calculated as % of 
EGFP-positive cells and shown as relative L1 mobility to human IPSC1. (g) Representative 
images of human, chimpanzee and bonobo iPSCs transfected with L1-EGFP. (h) 
Retrotransposition quantitation of species-specific L1 elements. Human and Chimp reporter 
L1-EGFP elements (human-L1 and chimp-L1, respectively) mobility was quantified in 
transfected in human, chimp and bonobo iPSCs. Retrotranposition activity is shown as 
relative to Human-L1 activity in human iPSCs. Error bars, s.e.m. *P<0.01 between indicated 
groups using t-test (for a,b,e,f n=3 biological replicates; d and h n=4 biological replicates).
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Figure 4. Species-specific L1 elements are more abundant in chimpanzee genomes than in 
human genomes, correlating with decreased levels of A3B and PIWIL2
(a) Stable knockdown of A3B (shA3B-1, shA3B-2) or control (shScr) in human iPSCs. A3B 
expression was normalized to GAPDH and shown as relative to shScr. (b) L1-EGFP 
mobility in shA3B iPSCs. EGFP-positive cells were quantified by FACS analysis and shown 
as relative to shScr iPSC line. (c,d) Overexpression of A3B (c) and PIWIL2 (d) decreases 
L1-EGFP retrotransposition in NHP iPSCs. Cells were electroporated with L1-EGFP plus 
control (CTR), A3B or PIWIL2 expressing plasmids. L1-EGFP mobility is shown as relative 
to human iPSC-1 CTR. (e) Immunoprecipitation of piRNAs associated with PIWIL2 in 
human iPSCs. (Top) Immunoprecipitation of PIWIL2 RNPs from Tet-inducible GFP and 
Flag-tagged PIWIL2 human iPSCs after addition of Doxycycline. (Bottom) γ32P-ATP 5’end 
labeling of RNA associated with Flag-PIWIL2 RNPs. Size markers are indicated. (f) 
Mapping of 26-33 nt RNA reads (containing uracil in the 5’end and/or adenine at position 
+10) detected by small RNA-seq from hiPSC1 and hiPSC2 to consensus L1Hs (Repbase). 
Positive and negative values indicate sense and antisense piRNAs,, respectively. Schematic 
representation of L1 is shown on top. Y-axes: read counts normalized to 107 reads per 
experiment. (g) Quantitative RT-PCR analysis of endogenous L1 RNA in human and NHP 
iPSCs. Values represent the average of relative levels for L1 RNA (5’UTR, ORF1, ORF2) 
normalized to Actin mRNA levels. L1 levels are shown as relative to IPSC-1. (h) 
Comparative quantitative analysis of L1 elements in human and chimpanzee genomes for L1 
families L1PA4, L1PA3, L1PA2, L1Pt and L1Hs. (i) Number of species-specific L1 
insertions (L1PA2, L1Hs, L1Pt) relative to their divergence. L1 elements plotted as a 
histogram relative to their divergence (number of mutations relative to the canonical 
element). Error bars: s.d.. *P<0.001 between human and chimpanzee, Mann-Whitney test 
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(a,b,c,d and g, error bars: s.e.m., *P<0.01 between indicated groups, t-test, a,b,c and d, n=3; 
g n=4 biological replicates).
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Extended Data Figure 1. 
Cell lines used in this study, number of mapped reads per sample in RNA-seq and gene 
ontology (GO) enrichment analysis for differentially expressed genes. (a) Origin of iPSCs 
used or generated in this study. (c,d) GO enrichment analysis of differentially expressed 
genes. (b) Total number of mapped reads per sample in RNA-seq (c) Top 10 enriched GO 
terms for genes with higher expression in human versus NHP iPSCs. (d) Top 10 enriched 
GO terms for genes highly expressed in NHP versus human iPSCs. GO analysis was 
restricted to differentially expressed protein-coding genes (FDR <0.05 and FC >2). GO 
enrichment for biological processes (level 2) was performed using DAVID. Figure shows 
GO term, number of genes (count), and p values for EASE score and Benjamini adjustment.
Marchetto et al. Page 19
Nature. Author manuscript; available in PMC 2014 June 20.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Extended Data Figure 2. 
Amino acid alignment of A3B and PIWIL2. Protein sequences of human, chimp and 
bonobo A3B (a) or PIWIL2 (b) were aligned using ClustalW. (a) Alignment of A3B 
showing >93% identity between human and NHP proteins. (b) Alignment of PIWIL2 
showing >98% identity between human and NHP proteins.
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Extended Data Figure 3. 
mRNA levels of APOBEC3 and PIWI-like family members in iPSCs. (a) Comparative 
analysis of PIWIL2 mRNA levels. Quantitative RT-PCR analysis of PIWIL2 mRNA levels 
in human testis, human iPSC cell lines and available fibroblasts from, which the iPSC lines 
were derived from. mRNA levels were normalized to GAPDH and shown as relative to 
human testis (mean ± s.e.m.; n=3 biological replicates). Compared to testis, PIWIL2 levels 
are 20 to 40 fold lower in iPSCs and ~1,100-fold lower in fibroblasts. (b,c). Quantification 
of mRNA levels of APOBEC3 and PIWI-like family members in human and NHP iPSCs by 
RNA-seq. Increased mRNA levels in human iPSCs is restricted for APOBEC3B and 
PIWIL2. Y-axes: reads per kilobase per million mapped reads (RPKM).
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Extended Data Figure 4. 
L1 reporter activity in iPSCs. (a) L1 retrotransposition reporter system. The L1-reporter 
plasmid harbors a retrotransposition-competent human L1 element and carries either a EGFP 
or a Luciferase (Luc) reporter construct in its 3’ UTR region. The reporter gene is 
interrupted by an intron in the same transcriptional orientation as the L1 transcript. This 
arrangement ensures that EGFP/Luc-positive cells will arise only when a transcript initiated 
from the promoter driving L1 expression is spliced, reverse transcribed, and integrated into 
chromosomal DNA, thereby allowing expression of the reporter gene from a heterologous 
promoter. (b-f) Efficient A3B knockdown in human ESCs and iPSCs. (b) Stable shRNA-
mediated knockdown of A3B in hESCs (Hues6) using lentivirus expressing different 
shRNAs against A3B (shA3B-1 and shA3B-2) or control shScramble (shScr). Levels of 
A3B expression were normalized for GAPDH and shown as relative to shScr (mean ± 
s.e.m.; n=3 biological replicates). (c) Western blot confirming stable A3B knockdown in 
hESCs. (d-f) shRNA-mediated knockdown in hESC (Hues6) and iPSC-1 and iPSC-2 (WT33 
and Adrc40) was specific for A3B. (g-h) Quantitative RT-PCR analysis of plasmid 
expression in iPSC lines transfected with L1-EGFP plasmid. Total RNA samples were 
obtained 60-72 hours post-transfection. L1 plasmid-driven EGFP expression was normalized 
to GAPDH (g) or Puromycin (h). L1-EGFP contains a puromycin expression cassette under 
PGK promoter control. Thus, puromycin expression can be used as normalizer for 
transfection. IPSCs from two different individuals per species were transfected, and EGFP 
levels are shown as relative to human iPSCs. No significant differences were observed for 
L1 plasmid expression between human and NHP iPSC lines (mean ± s.e.m.;n=3 biological 
replicates). (i) Relative L1 5’UTR promoter activity. Human and chimp L1 promoters (L1 
5’UTR) were inserted upstream of firefly luciferase reporter in pGL4.10 and transfected into 
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human and NHP iPSC lines. A plasmid expressing Renila luciferase was co-transfected as 
control. 72 hours post transfection luciferase activity was quantified as firefly luciferase 
units relative to renilla luciferase units. Results are shown as normalized to human L1 
5’UTR activity in human iPSC. IPSCs from two different individuals per species were 
transfected. No significant differences were observed for L1 promoter activities between 
human and NHP iPSC lines (mean ± s.e.m; n=4 biological replicates).
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Extended Data Figure 5. 
Nucleic acid alignment of human and chimpanzee L1 elements. Sequence of the chimpanzee 
L1Pt element cloned and used to generate the chimpanzee L1-EGFP tagged reporter plasmid 
(L1IN71) (top sequence). LRE3: human L1 (bottom sequence).
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Extended Data Figure 6. 
Immunoprecipitation of piRNAs associated with PIWIL2 in human iPSCs and annotated 
piRNAs mapping to consensus L1Hs in iPSCs. (a) Immunoprecipitation of PIWIL2 RNPs 
using Flag-tag antibodies from Tet-inducible Flag-tagged PIWIL2 human iPSCs after 
addition of Doxyclycine to the culture media. HA-tag antibody was used as control. (b), 
γ32P-ATP end labeling of RNAs associated with Flag-PIWIL2 RNPs. Signal in the piRNAs 
size range is detected only in anti-Flag but not in control antibody anti-HA 
immunoprecipitates. (c) Size distribution of RNA reads detected by small RNA-seq from 
small RNAs samples extracted from human iPSC cell lines (hiPSC1 and hiPSC2). (d) 
Number of mapped reads per sample in small RNA-seq. (e) Number of annotated piRNAs 
(piRNAbank) detected by RNA-seq in human iPSC1 and iPSC2. (f) Characterization of 5’ 
end of piRNAs detected in human iPSCs relative to annotated piRNAs. Read count 
distribution relative to piRNA 5' ends (piRNAbank). (g) Sequences of annotated piRNAs 
(piRNAbank) mapping to consensus L1Hs detected in human iPSC1 and iPSC2. 26-33nt 
RNA reads from human iPS cell lines 1 and 2 (hiPSC1 and hiPSC2) characterized by 
RNASeq are aligned to annotated piRNAs mapping to the consensus L1Hs sequence. 
Analysis of mapping sequences was performed allowing 2 mismatches.
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Extended Data Figure 7. 
Mapping of 26-33 nt RNAs in human iPSCs to consensus L1Hs. (a) Mapping of annotated 
piRNAs (piRNAbank) detected by RNA-seq from human iPSC lines (hiPSC1 and hiPSC2) 
to the consensus sequence for L1Hs (from Repbase). All annotated piRNAs (piRNAbank) 
complementary to the L1Hs are indicated (black bars). (b) Total 26-33 nt RNA reads 
characterized by small RNA seq mapped to L1Hs. (c) Similar analysis as in (b) of ENCODE 
data for small RNAs from human ES H1 cells (hESC H1). Positive and negative values 
indicate sense and antisense piRNAs (+/−), respectively. Schematic representation of the 
L1Hs element is shown (top). Y-axes represent read counts normalized to 107 reads per 
experiment.
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Extended Data Figure 8. 
Higher levels of endogenous L1 RNA and recent species-specific L1 elements in 
chimpanzee. (a) Scheme of amplicons mapped to the L1Hs consensus sequence. Six primer 
pairs (two per region) were used for quantification of 5'UTR, ORF1 and ORF2. The primers 
were designed to recognize both species-specific and common families. (b) Positions of the 
amplicons in L1Hs consensus sequence and the number of in silico PCR hits on the Human 
and Chimp genomes. (c) Quantitative RT-PCR analysis using primers for different regions 
of L1 element show higher levels of L1 RNA in NHP iPSCs regardless of the L1 region 
tested: 5’-UTR, ORF1 and ORF2. (mean ± s.e.m.; n=3 biological replicates; *P<0.01 
between indicated groups, t-test). (dg) Quantification of L1 elements in human and 
chimpanzee genomes using a population divergence model. Number of L1 elements found 
in the human and chimpanzee genomes for families: L1PA4 (d), L1PA3 (e), L1PA2 (f), and 
L1Pt and L1Hs (g) plotted as a histogram relative to their divergence (number of mutations 
relative to the canonical element). The standard deviation describes the differences in L1 
density based on the sampling of different genomic regions and represents the variability of 
L1 coverage across the genomes (see methods).
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Extended Data Figure 9. 
Relative APOBEC3B and PIWIL2 mRNA levels in iPSC and fibroblasts. Relative 
expression of (a) A3B and (b) PIWIL2 in human and NHP iPSC lines, and the available 
source fibroblasts from, which iPSCs were derived from. mRNA levels were normalized to 
GAPDH and shown as relative to human iPSC1.
Marchetto et al. Page 28
Nature. Author manuscript; available in PMC 2014 June 20.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Marchetto et al. Page 29
Extended Data Table 1
List of primers used in this study.
Primers Sequence Use
Nanog-F 5’- CCTATGCCTGTGATTTGTGG -3’ PCR
Nanog-R 5’- CTGGGACCTTGTCTTCCTTT -3’ PCR
AFP-F 5’- AAAAGCCCACTCCAGCATC -3’ PCR
AFP-R 5’- CAGACAATCCAGCACATCTC -3’ PCR
Musashi-F 5’- AAAGGAGGTGATGTCGCCAA -3’ PCR
Musashi-R 5’- TGGTCCGTAGGCAGTGAGA -3’ PCR
Brachyury-F 5’- GCCCTCTCCCTCCCCTCCACGCACAG -3’ PCR
Brachyury-R 5’- CGGCGCCGTTGCTCACAGACCACAGG -3’ PCR
B-Actin-F 5′- TGTTTTCTGCGCAAGTTAGGTTTT -3′ PCR
B-Actin-R 5′- GCCGACAGGATGCAGAAGGAGAT -3′ PCR
APOBEC3B (20-40) 5′-GCGGGACAGGGACAAGCGTAT-3′ Cloning
APOPEC3B (1250-1228) 5′-CTGCTCAACCCAGGTCTCTGCCT-3′ Cloning
APOBEC3B (19-41) 5′-AGCGGGACAGGGACAAGC GTATC-3′ Cloning
APOBEC3B(1309-1288) 5′-AGCTGGAGATGGTGGTGAACGG-3′ Cloning
L1Pt ch7 11 F 5′-TTGCAGGTACTCTGAGCTTCAC-3′ Cloning
L1Pt ch7 11 R 5’-AAGGAGAAGCACCTGCATGA-3’ Cloning
Not-L1 F 5’-ATAAGAATGCGGCCGCGGGGGAGGAGCCAAGATG-3’ Cloning
XhoINotI L1 5UTR 5’-CCGCTCGAGCGGCCGCGGGGGAGGAG-3’ Cloning
L1 5UTRHindIIIATG 5”-TTTTTAAGCTTCCATCTTTGTGGTTTTATCTAC-3” Cloning
APOBEC3B-F 5’-CGCCAGACCTACTTGTGCTAT-3’ qPCR
APOBEC3B-R 5’-CATTTGCAGCGCCTCCTTAT-3’ qPCR
GAPDH-F 5’- CATGTTCCAATATGATTCCACC-3’ qPCR
GAPDH-R 5’- CTCCACGACGTACTCAGCG-3’ qPCR
PIWIL2-F 5′- TTGTGGACAGCCTGAAGCTA -3′ qPCR
PIWIL2-R 5′- CCATCAGACACTCCATCACG -3′ qPCR
L1 5’UTR set1-R 5’-AAGATGGCCGAATAGGAACA-3’ qPCR
L1 5’UTR set1-R 5’-GATGAACCCGGTACCTCAGA-3’ qPCR
L1 5’UTR set2-R 5’-GAGATCTGAGAACGGGCAGA-3’ qPCR
L1 5’UTR set2-R 5’-AGCTGCAGGTCTGTTGGAAT-3’ qPCR
L1 ORF1 set1-F 5’-GCTACGGGAGGACATTCAAA-3’ qPCR
L1 ORF1 set1-R 5’-TTCAGCTCCATCAGCTCCTT-3’ qPCR
L1 ORF1 set2-F 5’-ATGAGCAAAGCCTCCAAGAA-3’ qPCR
L1ORF1 set2-R 5’-TTCTCCCCATCACTTTCAGG-3’ qPCR
L1 ORF2 set1-F 5’-TGACAAACCCACAGCCAATA-3’ qPCR
L1 ORF2 set1-R 5’-CCCTGTCTTGTGCCAGTTTT-3’ qPCR
L1 ORF2 set2-F 5′-TGGAGGCATCACACTACCTG-3′ qPCR
L1 ORF2 set2-R 5′-ATGCGGCATTATTTCTGAGG-3′ qPCR
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Primers Sequence Use
Actin-F 5′- TACAATGAGCTGCGTGTGG-3′ qPCR
Actin-R 5′- TAGCACAGCCTGGATAGCAA-3′ qPCR
GFP F2 5′- GGGTGTTCTGCTGGTAGTGG-3′ qPCR
GFP R2 5′- TATATCATGGCCGACAAGCA-3′ qPCR
PURO F 5′- CTCGACATCGGCAAGGTGTG-3′ qPCR
PURO R 5′- GCCTTCCATCTGTTGCTGCG-3′ qPCR
APOBEC3A TaqMan Assay (Life Technologies) Hs00377444 qPCR
APOBEC3B TaqMan Assay (Life Technologies) Hs00358981 qPCR
APOBEC3C TaqMan Assay (Life Technologies) Hs00828074 qPCR
APOBEC3D TaqMan Assay (Life Technologies) Hs00537163 qPCR
APOBEC3F TaqMan Assay (Life Technologies) Hs01665324 qPCR
APOBEC3G TaqMan Assay (Life Technologies) Hs00222415 qPCR
APOBEC3H TaqMan Assay (Life Technologies) Hs00962174 qPCR
PIWIL2 TaqMan Assay (Life Technologies) Hs01032720 qPCR
GAPDH TaqMan Assay (Life Technologies) Hs03929097 qPCR
HPRT TaqMan Assay (Life Technologies) Hs01003267 qPCR
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